AU2003254001A1 - Novel htnfsf13b protein variants - Google Patents

Novel htnfsf13b protein variants

Info

Publication number: AU2003254001A1
Authority: AU; Australia
Prior art keywords: htnfsf13b; novel; protein variants; variants; protein
Prior art date: 2002-08-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003254001A

Other versions

AU2003254001A8 (en

Inventor

Kristine Kay Kikly

Radhakrishnan Rathnachalam

Derrick Ryan Witcher

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-14

Filing date

2003-08-11

Publication date

2004-03-03

2003-08-11 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2004-03-03 Publication of AU2003254001A1 publication Critical patent/AU2003254001A1/en

2004-03-03 Publication of AU2003254001A8 publication Critical patent/AU2003254001A8/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

AU2003254001A 2002-08-14 2003-08-11 Novel htnfsf13b protein variants Abandoned AU2003254001A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US40321402P	2002-08-14	2002-08-14
US60/403,214		2002-08-14
PCT/US2003/022505 WO2004016737A2 (en)	2002-08-14	2003-08-11	Novel htnfsf13b protein variants

Publications (2)

Publication Number	Publication Date
AU2003254001A1 true AU2003254001A1 (en)	2004-03-03
AU2003254001A8 AU2003254001A8 (en)	2004-03-03

Family

ID=31888217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003254001A Abandoned AU2003254001A1 (en)	2002-08-14	2003-08-11	Novel htnfsf13b protein variants

Country Status (2)

Country	Link
AU (1)	AU2003254001A1 (en)
WO (1)	WO2004016737A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030095967A1 (en)	1999-01-25	2003-05-22	Mackay Fabienne	BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
CA2554526A1 (en)	2004-01-29	2005-08-18	Genentech, Inc.	Variants of the extracellular domain of bcma and uses thereof
AU2005295713B2 (en)	2004-10-13	2011-06-16	The Washington University	Use of BAFF to treat sepsis
BR112016011003A2 (en)	2013-11-19	2017-12-05	Regeneron Pharma	genetically modified rodent animal, mouse embryonic stem cell, mouse embryo, and methods for making a rodent animal and grafting human cells into a mouse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6812327B1 (en) *	1996-10-25	2004-11-02	Human Genome Sciences, Inc.	Neutrokine-alpha polypeptides
US6297367B1 (en) *	1997-12-30	2001-10-02	Chiron Corporation	Polynucleotide encoding TNFL1

2003
- 2003-08-11 WO PCT/US2003/022505 patent/WO2004016737A2/en not_active Application Discontinuation
- 2003-08-11 AU AU2003254001A patent/AU2003254001A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004016737A3 (en)	2006-01-05
WO2004016737A2 (en)	2004-02-26
AU2003254001A8 (en)	2004-03-03

Similar Documents

Publication	Publication Date	Title
AU2003272454A1 (en)	2004-04-08	Protein purification
AU2003254001A1 (en)	2004-03-03	Novel htnfsf13b protein variants
AU2003202694A1 (en)	2003-09-02	Torero protein
AU2003278718A1 (en)	2004-03-11	Stars-a muscle-specification-binding protein
AU2003270055A1 (en)	2004-03-29	Neurotransmission-associated proteins
PL376318A1 (en)	2005-12-27	Protein modification
AU2003300785A1 (en)	2004-06-03	Carbohydrate-associated proteins
GB0206684D0 (en)	2002-05-01	Novel proteins
AU2003254865A1 (en)	2004-02-25	Akt2-BINDING PROTEIN
AU2003232176A1 (en)	2003-12-31	Protein c variants with altered properties
AU2003295760A1 (en)	2004-06-18	Organelle-associated proteins
AU2003236908A1 (en)	2004-01-06	Proteins
AU2003218714A1 (en)	2003-09-22	Rhomboid-related protein
AU2003281671A1 (en)	2004-02-16	Brca1-interacting protein
AU2003211532A1 (en)	2003-09-09	Novel polypeptide
GB0220038D0 (en)	2002-10-09	Novel Protein Design
GB0204735D0 (en)	2002-04-17	Protein
GB0202748D0 (en)	2002-03-27	Protein
AU2003205825A1 (en)	2003-09-02	Polypeptide variants
GB0214703D0 (en)	2002-08-07	Novel protein
AUPS130102A0 (en)	2002-05-09	Novel peptides
AU2003257392A1 (en)	2004-03-03	Fluorescent protein
AU2003303642A1 (en)	2004-07-29	Synthetic neutropoiesis-stimulating proteins
AU2003905886A0 (en)	2003-11-06	Protein expression
AU2002243916A1 (en)	2002-08-19	Timm8b-related protein

Legal Events

Date	Code	Title	Description
2005-04-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase